F.or years now, biologists have practiced a kind of time travel. You can take a piece of human skin and, with the right genetic modifications, turn back the inner clock until it becomes its embryonic self, stripped of its identity, and ready to become just about any human body part. Since the method’s publication in 2006, transforming adult cells into stem cells has enabled all kinds of advances. Researchers can grow organs in dishes. They can replicate what’s happening in the womb without the regulatory headaches of getting fetal tissue. It became an everyday tool on laboratory benches around the world and won a Nobel Prize.
But for David Sinclair’s purposes that was not good enough. His interest was in reversing the slings and arrows of old age, using that genetic time machine to create something that would be truly therapeutic. When cells were backwashed to an embryo-like state, they did what embryonic cells do: divide like crazy. Beyond the complicated control of the prenatal environment, that led to cancer. The mice used in such experiments died within days. “We wanted to take back the age of a tissue, but find a way to keep it from going back too far,” said Sinclair, a professor of genetics at Harvard Medical School.
What is it?
STAT + is STAT’s premium subscription service for in-depth biotech, pharma, policy and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early scientific breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What is included?
- Daily reporting and analysis
- The most comprehensive coverage in the industry from a powerful team of reporters
- Newsletters for subscribers
- Daily newsletters to keep you informed of the most important industry news of the day
- STAT + conversations
- Weekly opportunities to engage in live video calls with our reporters and leading industry experts
- Exclusive industry events
- Premium access to networking events for subscribers across the country
- The best reporters in the business
- The most trusted and well-connected newsroom in the healthcare industry
- And much more
- Exclusive interviews with industry leaders, profiles and premium tools, such as our CRISPR Trackr.
Source link